Accueil   Diary - News   All news Adocia initiates a clinical study

Adocia initiates a clinical study

Adocia announced the initiation of a Phase I clinical trial evaluating a new and more concentrated formulation of BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Eli Lilly and Company. This formulation uses Adocia’s proprietary BioChaperone technology, which enables the acceleration of insulin absorption.

Read the press release